Global Parkinson’s Disease Treatment Market Research Report 2023

Report ID: 2010973 | Published Date: Jan 2025 | No. of Page: 95 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Parkinson’s Disease Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 Oral
        1.2.3 Transdermal
        1.2.4 Subcutaneous
        1.2.5 Intestinal Infusion
    1.3 Market by Application
        1.3.1 Global Parkinson’s Disease Treatment Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Hospital Pharmacy
        1.3.3 Retail Pharmacy
        1.3.4 Online Pharmacy
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered
2 Global Growth Trends
    2.1 Global Parkinson’s Disease Treatment Market Perspective (2018-2029)
    2.2 Parkinson’s Disease Treatment Growth Trends by Region
        2.2.1 Global Parkinson’s Disease Treatment Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 Parkinson’s Disease Treatment Historic Market Size by Region (2018-2023)
        2.2.3 Parkinson’s Disease Treatment Forecasted Market Size by Region (2024-2029)
    2.3 Parkinson’s Disease Treatment Market Dynamics
        2.3.1 Parkinson’s Disease Treatment Industry Trends
        2.3.2 Parkinson’s Disease Treatment Market Drivers
        2.3.3 Parkinson’s Disease Treatment Market Challenges
        2.3.4 Parkinson’s Disease Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Parkinson’s Disease Treatment Players by Revenue
        3.1.1 Global Top Parkinson’s Disease Treatment Players by Revenue (2018-2023)
        3.1.2 Global Parkinson’s Disease Treatment Revenue Market Share by Players (2018-2023)
    3.2 Global Parkinson’s Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Parkinson’s Disease Treatment Revenue
    3.4 Global Parkinson’s Disease Treatment Market Concentration Ratio
        3.4.1 Global Parkinson’s Disease Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Parkinson’s Disease Treatment Revenue in 2022
    3.5 Parkinson’s Disease Treatment Key Players Head office and Area Served
    3.6 Key Players Parkinson’s Disease Treatment Product Solution and Service
    3.7 Date of Enter into Parkinson’s Disease Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Parkinson’s Disease Treatment Breakdown Data by Type
    4.1 Global Parkinson’s Disease Treatment Historic Market Size by Type (2018-2023)
    4.2 Global Parkinson’s Disease Treatment Forecasted Market Size by Type (2024-2029)
5 Parkinson’s Disease Treatment Breakdown Data by Application
    5.1 Global Parkinson’s Disease Treatment Historic Market Size by Application (2018-2023)
    5.2 Global Parkinson’s Disease Treatment Forecasted Market Size by Application (2024-2029)
6 North America
    6.1 North America Parkinson’s Disease Treatment Market Size (2018-2029)
    6.2 North America Parkinson’s Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America Parkinson’s Disease Treatment Market Size by Country (2018-2023)
    6.4 North America Parkinson’s Disease Treatment Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada
7 Europe
    7.1 Europe Parkinson’s Disease Treatment Market Size (2018-2029)
    7.2 Europe Parkinson’s Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe Parkinson’s Disease Treatment Market Size by Country (2018-2023)
    7.4 Europe Parkinson’s Disease Treatment Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Parkinson’s Disease Treatment Market Size (2018-2029)
    8.2 Asia-Pacific Parkinson’s Disease Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific Parkinson’s Disease Treatment Market Size by Region (2018-2023)
    8.4 Asia-Pacific Parkinson’s Disease Treatment Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia
9 Latin America
    9.1 Latin America Parkinson’s Disease Treatment Market Size (2018-2029)
    9.2 Latin America Parkinson’s Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America Parkinson’s Disease Treatment Market Size by Country (2018-2023)
    9.4 Latin America Parkinson’s Disease Treatment Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Parkinson’s Disease Treatment Market Size (2018-2029)
    10.2 Middle East & Africa Parkinson’s Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa Parkinson’s Disease Treatment Market Size by Country (2018-2023)
    10.4 Middle East & Africa Parkinson’s Disease Treatment Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE
11 Key Players Profiles
    11.1 Teva
        11.1.1 Teva Company Detail
        11.1.2 Teva Business Overview
        11.1.3 Teva Parkinson’s Disease Treatment Introduction
        11.1.4 Teva Revenue in Parkinson’s Disease Treatment Business (2018-2023)
        11.1.5 Teva Recent Development
    11.2 Roche
        11.2.1 Roche Company Detail
        11.2.2 Roche Business Overview
        11.2.3 Roche Parkinson’s Disease Treatment Introduction
        11.2.4 Roche Revenue in Parkinson’s Disease Treatment Business (2018-2023)
        11.2.5 Roche Recent Development
    11.3 Prothena
        11.3.1 Prothena Company Detail
        11.3.2 Prothena Business Overview
        11.3.3 Prothena Parkinson’s Disease Treatment Introduction
        11.3.4 Prothena Revenue in Parkinson’s Disease Treatment Business (2018-2023)
        11.3.5 Prothena Recent Development
    11.4 Acorda Therapeutics
        11.4.1 Acorda Therapeutics Company Detail
        11.4.2 Acorda Therapeutics Business Overview
        11.4.3 Acorda Therapeutics Parkinson’s Disease Treatment Introduction
        11.4.4 Acorda Therapeutics Revenue in Parkinson’s Disease Treatment Business (2018-2023)
        11.4.5 Acorda Therapeutics Recent Development
    11.5 Voyager Therapeutics
        11.5.1 Voyager Therapeutics Company Detail
        11.5.2 Voyager Therapeutics Business Overview
        11.5.3 Voyager Therapeutics Parkinson’s Disease Treatment Introduction
        11.5.4 Voyager Therapeutics Revenue in Parkinson’s Disease Treatment Business (2018-2023)
        11.5.5 Voyager Therapeutics Recent Development
    11.6 Impax Pharmaceuticals
        11.6.1 Impax Pharmaceuticals Company Detail
        11.6.2 Impax Pharmaceuticals Business Overview
        11.6.3 Impax Pharmaceuticals Parkinson’s Disease Treatment Introduction
        11.6.4 Impax Pharmaceuticals Revenue in Parkinson’s Disease Treatment Business (2018-2023)
        11.6.5 Impax Pharmaceuticals Recent Development
    11.7 UCB
        11.7.1 UCB Company Detail
        11.7.2 UCB Business Overview
        11.7.3 UCB Parkinson’s Disease Treatment Introduction
        11.7.4 UCB Revenue in Parkinson’s Disease Treatment Business (2018-2023)
        11.7.5 UCB Recent Development
    11.8 AbbVie
        11.8.1 AbbVie Company Detail
        11.8.2 AbbVie Business Overview
        11.8.3 AbbVie Parkinson’s Disease Treatment Introduction
        11.8.4 AbbVie Revenue in Parkinson’s Disease Treatment Business (2018-2023)
        11.8.5 AbbVie Recent Development
    11.9 MSD
        11.9.1 MSD Company Detail
        11.9.2 MSD Business Overview
        11.9.3 MSD Parkinson’s Disease Treatment Introduction
        11.9.4 MSD Revenue in Parkinson’s Disease Treatment Business (2018-2023)
        11.9.5 MSD Recent Development
    11.10 Orion Pharmaceuticals
        11.10.1 Orion Pharmaceuticals Company Detail
        11.10.2 Orion Pharmaceuticals Business Overview
        11.10.3 Orion Pharmaceuticals Parkinson’s Disease Treatment Introduction
        11.10.4 Orion Pharmaceuticals Revenue in Parkinson’s Disease Treatment Business (2018-2023)
        11.10.5 Orion Pharmaceuticals Recent Development
    11.11 Intec Pharma
        11.11.1 Intec Pharma Company Detail
        11.11.2 Intec Pharma Business Overview
        11.11.3 Intec Pharma Parkinson’s Disease Treatment Introduction
        11.11.4 Intec Pharma Revenue in Parkinson’s Disease Treatment Business (2018-2023)
        11.11.5 Intec Pharma Recent Development
    11.12 NeuroDerm
        11.12.1 NeuroDerm Company Detail
        11.12.2 NeuroDerm Business Overview
        11.12.3 NeuroDerm Parkinson’s Disease Treatment Introduction
        11.12.4 NeuroDerm Revenue in Parkinson’s Disease Treatment Business (2018-2023)
        11.12.5 NeuroDerm Recent Development
    11.13 Adamas Therapeutics
        11.13.1 Adamas Therapeutics Company Detail
        11.13.2 Adamas Therapeutics Business Overview
        11.13.3 Adamas Therapeutics Parkinson’s Disease Treatment Introduction
        11.13.4 Adamas Therapeutics Revenue in Parkinson’s Disease Treatment Business (2018-2023)
        11.13.5 Adamas Therapeutics Recent Development
    11.14 Acadia
        11.14.1 Acadia Company Detail
        11.14.2 Acadia Business Overview
        11.14.3 Acadia Parkinson’s Disease Treatment Introduction
        11.14.4 Acadia Revenue in Parkinson’s Disease Treatment Business (2018-2023)
        11.14.5 Acadia Recent Development
    11.15 Sunovion
        11.15.1 Sunovion Company Detail
        11.15.2 Sunovion Business Overview
        11.15.3 Sunovion Parkinson’s Disease Treatment Introduction
        11.15.4 Sunovion Revenue in Parkinson’s Disease Treatment Business (2018-2023)
        11.15.5 Sunovion Recent Development
    11.16 GSK
        11.16.1 GSK Company Detail
        11.16.2 GSK Business Overview
        11.16.3 GSK Parkinson’s Disease Treatment Introduction
        11.16.4 GSK Revenue in Parkinson’s Disease Treatment Business (2018-2023)
        11.16.5 GSK Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Parkinson’s Disease Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Oral
    Table 3. Key Players of Transdermal
    Table 4. Key Players of Subcutaneous
    Table 5. Key Players of Intestinal Infusion
    Table 6. Global Parkinson’s Disease Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 7. Global Parkinson’s Disease Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 8. Global Parkinson’s Disease Treatment Market Size by Region (2018-2023) & (US$ Million)
    Table 9. Global Parkinson’s Disease Treatment Market Share by Region (2018-2023)
    Table 10. Global Parkinson’s Disease Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 11. Global Parkinson’s Disease Treatment Market Share by Region (2024-2029)
    Table 12. Parkinson’s Disease Treatment Market Trends
    Table 13. Parkinson’s Disease Treatment Market Drivers
    Table 14. Parkinson’s Disease Treatment Market Challenges
    Table 15. Parkinson’s Disease Treatment Market Restraints
    Table 16. Global Parkinson’s Disease Treatment Revenue by Players (2018-2023) & (US$ Million)
    Table 17. Global Parkinson’s Disease Treatment Market Share by Players (2018-2023)
    Table 18. Global Top Parkinson’s Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson’s Disease Treatment as of 2022)
    Table 19. Ranking of Global Top Parkinson’s Disease Treatment Companies by Revenue (US$ Million) in 2022
    Table 20. Global 5 Largest Players Market Share by Parkinson’s Disease Treatment Revenue (CR5 and HHI) & (2018-2023)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Parkinson’s Disease Treatment Product Solution and Service
    Table 23. Date of Enter into Parkinson’s Disease Treatment Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Parkinson’s Disease Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 26. Global Parkinson’s Disease Treatment Revenue Market Share by Type (2018-2023)
    Table 27. Global Parkinson’s Disease Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 28. Global Parkinson’s Disease Treatment Revenue Market Share by Type (2024-2029)
    Table 29. Global Parkinson’s Disease Treatment Market Size by Application (2018-2023) & (US$ Million)
    Table 30. Global Parkinson’s Disease Treatment Revenue Market Share by Application (2018-2023)
    Table 31. Global Parkinson’s Disease Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 32. Global Parkinson’s Disease Treatment Revenue Market Share by Application (2024-2029)
    Table 33. North America Parkinson’s Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 34. North America Parkinson’s Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 35. North America Parkinson’s Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 36. Europe Parkinson’s Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 37. Europe Parkinson’s Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 38. Europe Parkinson’s Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 39. Asia-Pacific Parkinson’s Disease Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 40. Asia-Pacific Parkinson’s Disease Treatment Market Size by Region (2018-2023) & (US$ Million)
    Table 41. Asia-Pacific Parkinson’s Disease Treatment Market Size by Region (2024-2029) & (US$ Million)
    Table 42. Latin America Parkinson’s Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 43. Latin America Parkinson’s Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 44. Latin America Parkinson’s Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 45. Middle East & Africa Parkinson’s Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 46. Middle East & Africa Parkinson’s Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 47. Middle East & Africa Parkinson’s Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 48. Teva Company Detail
    Table 49. Teva Business Overview
    Table 50. Teva Parkinson’s Disease Treatment Product
    Table 51. Teva Revenue in Parkinson’s Disease Treatment Business (2018-2023) & (US$ Million)
    Table 52. Teva Recent Development
    Table 53. Roche Company Detail
    Table 54. Roche Business Overview
    Table 55. Roche Parkinson’s Disease Treatment Product
    Table 56. Roche Revenue in Parkinson’s Disease Treatment Business (2018-2023) & (US$ Million)
    Table 57. Roche Recent Development
    Table 58. Prothena Company Detail
    Table 59. Prothena Business Overview
    Table 60. Prothena Parkinson’s Disease Treatment Product
    Table 61. Prothena Revenue in Parkinson’s Disease Treatment Business (2018-2023) & (US$ Million)
    Table 62. Prothena Recent Development
    Table 63. Acorda Therapeutics Company Detail
    Table 64. Acorda Therapeutics Business Overview
    Table 65. Acorda Therapeutics Parkinson’s Disease Treatment Product
    Table 66. Acorda Therapeutics Revenue in Parkinson’s Disease Treatment Business (2018-2023) & (US$ Million)
    Table 67. Acorda Therapeutics Recent Development
    Table 68. Voyager Therapeutics Company Detail
    Table 69. Voyager Therapeutics Business Overview
    Table 70. Voyager Therapeutics Parkinson’s Disease Treatment Product
    Table 71. Voyager Therapeutics Revenue in Parkinson’s Disease Treatment Business (2018-2023) & (US$ Million)
    Table 72. Voyager Therapeutics Recent Development
    Table 73. Impax Pharmaceuticals Company Detail
    Table 74. Impax Pharmaceuticals Business Overview
    Table 75. Impax Pharmaceuticals Parkinson’s Disease Treatment Product
    Table 76. Impax Pharmaceuticals Revenue in Parkinson’s Disease Treatment Business (2018-2023) & (US$ Million)
    Table 77. Impax Pharmaceuticals Recent Development
    Table 78. UCB Company Detail
    Table 79. UCB Business Overview
    Table 80. UCB Parkinson’s Disease Treatment Product
    Table 81. UCB Revenue in Parkinson’s Disease Treatment Business (2018-2023) & (US$ Million)
    Table 82. UCB Recent Development
    Table 83. AbbVie Company Detail
    Table 84. AbbVie Business Overview
    Table 85. AbbVie Parkinson’s Disease Treatment Product
    Table 86. AbbVie Revenue in Parkinson’s Disease Treatment Business (2018-2023) & (US$ Million)
    Table 87. AbbVie Recent Development
    Table 88. MSD Company Detail
    Table 89. MSD Business Overview
    Table 90. MSD Parkinson’s Disease Treatment Product
    Table 91. MSD Revenue in Parkinson’s Disease Treatment Business (2018-2023) & (US$ Million)
    Table 92. MSD Recent Development
    Table 93. Orion Pharmaceuticals Company Detail
    Table 94. Orion Pharmaceuticals Business Overview
    Table 95. Orion Pharmaceuticals Parkinson’s Disease Treatment Product
    Table 96. Orion Pharmaceuticals Revenue in Parkinson’s Disease Treatment Business (2018-2023) & (US$ Million)
    Table 97. Orion Pharmaceuticals Recent Development
    Table 98. Intec Pharma Company Detail
    Table 99. Intec Pharma Business Overview
    Table 100. Intec Pharma Parkinson’s Disease Treatment Product
    Table 101. Intec Pharma Revenue in Parkinson’s Disease Treatment Business (2018-2023) & (US$ Million)
    Table 102. Intec Pharma Recent Development
    Table 103. NeuroDerm Company Detail
    Table 104. NeuroDerm Business Overview
    Table 105. NeuroDerm Parkinson’s Disease Treatment Product
    Table 106. NeuroDerm Revenue in Parkinson’s Disease Treatment Business (2018-2023) & (US$ Million)
    Table 107. NeuroDerm Recent Development
    Table 108. Adamas Therapeutics Company Detail
    Table 109. Adamas Therapeutics Business Overview
    Table 110. Adamas Therapeutics Parkinson’s Disease Treatment Product
    Table 111. Adamas Therapeutics Revenue in Parkinson’s Disease Treatment Business (2018-2023) & (US$ Million)
    Table 112. Adamas Therapeutics Recent Development
    Table 113. Acadia Company Detail
    Table 114. Acadia Business Overview
    Table 115. Acadia Parkinson’s Disease Treatment Product
    Table 116. Acadia Revenue in Parkinson’s Disease Treatment Business (2018-2023) & (US$ Million)
    Table 117. Acadia Recent Development
    Table 118. Sunovion Company Detail
    Table 119. Sunovion Business Overview
    Table 120. Sunovion Parkinson’s Disease Treatment Product
    Table 121. Sunovion Revenue in Parkinson’s Disease Treatment Business (2018-2023) & (US$ Million)
    Table 122. Sunovion Recent Development
    Table 123. GSK Company Detail
    Table 124. GSK Business Overview
    Table 125. GSK Parkinson’s Disease Treatment Product
    Table 126. GSK Revenue in Parkinson’s Disease Treatment Business (2018-2023) & (US$ Million)
    Table 127. GSK Recent Development
    Table 128. Research Programs/Design for This Report
    Table 129. Key Data Information from Secondary Sources
    Table 130. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Parkinson’s Disease Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Parkinson’s Disease Treatment Market Share by Type: 2022 VS 2029
    Figure 3. Oral Features
    Figure 4. Transdermal Features
    Figure 5. Subcutaneous Features
    Figure 6. Intestinal Infusion Features
    Figure 7. Global Parkinson’s Disease Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 8. Global Parkinson’s Disease Treatment Market Share by Application: 2022 VS 2029
    Figure 9. Hospital Pharmacy Case Studies
    Figure 10. Retail Pharmacy Case Studies
    Figure 11. Online Pharmacy Case Studies
    Figure 12. Parkinson’s Disease Treatment Report Years Considered
    Figure 13. Global Parkinson’s Disease Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 14. Global Parkinson’s Disease Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 15. Global Parkinson’s Disease Treatment Market Share by Region: 2022 VS 2029
    Figure 16. Global Parkinson’s Disease Treatment Market Share by Players in 2022
    Figure 17. Global Top Parkinson’s Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson’s Disease Treatment as of 2022)
    Figure 18. The Top 10 and 5 Players Market Share by Parkinson’s Disease Treatment Revenue in 2022
    Figure 19. North America Parkinson’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 20. North America Parkinson’s Disease Treatment Market Share by Country (2018-2029)
    Figure 21. United States Parkinson’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 22. Canada Parkinson’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 23. Europe Parkinson’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. Europe Parkinson’s Disease Treatment Market Share by Country (2018-2029)
    Figure 25. Germany Parkinson’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. France Parkinson’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. U.K. Parkinson’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. Italy Parkinson’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Russia Parkinson’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Nordic Countries Parkinson’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Asia-Pacific Parkinson’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Asia-Pacific Parkinson’s Disease Treatment Market Share by Region (2018-2029)
    Figure 33. China Parkinson’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. Japan Parkinson’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. South Korea Parkinson’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. Southeast Asia Parkinson’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. India Parkinson’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. Australia Parkinson’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 39. Latin America Parkinson’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. Latin America Parkinson’s Disease Treatment Market Share by Country (2018-2029)
    Figure 41. Mexico Parkinson’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. Brazil Parkinson’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. Middle East & Africa Parkinson’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Middle East & Africa Parkinson’s Disease Treatment Market Share by Country (2018-2029)
    Figure 45. Turkey Parkinson’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 46. Saudi Arabia Parkinson’s Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 47. Teva Revenue Growth Rate in Parkinson’s Disease Treatment Business (2018-2023)
    Figure 48. Roche Revenue Growth Rate in Parkinson’s Disease Treatment Business (2018-2023)
    Figure 49. Prothena Revenue Growth Rate in Parkinson’s Disease Treatment Business (2018-2023)
    Figure 50. Acorda Therapeutics Revenue Growth Rate in Parkinson’s Disease Treatment Business (2018-2023)
    Figure 51. Voyager Therapeutics Revenue Growth Rate in Parkinson’s Disease Treatment Business (2018-2023)
    Figure 52. Impax Pharmaceuticals Revenue Growth Rate in Parkinson’s Disease Treatment Business (2018-2023)
    Figure 53. UCB Revenue Growth Rate in Parkinson’s Disease Treatment Business (2018-2023)
    Figure 54. AbbVie Revenue Growth Rate in Parkinson’s Disease Treatment Business (2018-2023)
    Figure 55. MSD Revenue Growth Rate in Parkinson’s Disease Treatment Business (2018-2023)
    Figure 56. Orion Pharmaceuticals Revenue Growth Rate in Parkinson’s Disease Treatment Business (2018-2023)
    Figure 57. Intec Pharma Revenue Growth Rate in Parkinson’s Disease Treatment Business (2018-2023)
    Figure 58. NeuroDerm Revenue Growth Rate in Parkinson’s Disease Treatment Business (2018-2023)
    Figure 59. Adamas Therapeutics Revenue Growth Rate in Parkinson’s Disease Treatment Business (2018-2023)
    Figure 60. Acadia Revenue Growth Rate in Parkinson’s Disease Treatment Business (2018-2023)
    Figure 61. Sunovion Revenue Growth Rate in Parkinson’s Disease Treatment Business (2018-2023)
    Figure 62. GSK Revenue Growth Rate in Parkinson’s Disease Treatment Business (2018-2023)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Teva
Roche
Prothena
Acorda Therapeutics
Voyager Therapeutics
Impax Pharmaceuticals
UCB
AbbVie
MSD
Orion Pharmaceuticals
Intec Pharma
NeuroDerm
Adamas Therapeutics
Acadia
Sunovion
GSK
Frequently Asked Questions
Parkinson’s Disease Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Parkinson’s Disease Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Parkinson’s Disease Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Childhood Vaccines

This report aims to provide a comprehensive presentation of the global market for Childhood Vacci ... Read More

Travel Vaccines

This report aims to provide a comprehensive presentation of the global market for Travel Vaccines ... Read More